Health Care Spending Expected to Grow 5.6% Annually to 2025

This article originally appeared here.
Share this content:
Health Care Spending Expected to Grow 5.6% Annually to 2025
Health Care Spending Expected to Grow 5.6% Annually to 2025

THURSDAY, Feb. 16, 2017 (HealthDay News) -- Health care spending is expected to grow at an average annual rate of 5.6 percent from 2016 to 2025, according to a report published online Feb. 15 in Health Affairs.

Sean P. Keehan, from the U.S. Centers for Medicare and Medicaid Services in Baltimore, and colleagues address national health expenditure projections for 2016 to 2025.

The researchers note that for 2016 to 2025, national health expenditures are expected to grow at an annual rate of 5.6 percent; by 2025, expenditures are expected to represent 19.9 percent of the gross domestic product. National health expenditure is expected to have decreased 1.1 percent to 4.8 percent for 2016, resulting from slowing in Medicaid and prescription drug spending growth. Faster projected growth in medical prices is expected to be offset partially by slower projected growth in the use and intensity of medical goods and services for the rest of the projection period, relative to that seen in 2014 to 2016 in association with coverage expansions resulting from the Affordable Care Act. From 2015 to 2025, the insured share of the population is expected to increase from 90.9 to 91.5 percent.

"This analysis finds that under current law and following the recent significant period of transition associated with coverage expansions, health care enrollment and spending trends are projected to revert to being fundamentally driven by changes in economics and demographics," the authors write.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »